·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
µ¶ÀÚÁ¦º¸
Event
´º½º
Àüü±â»ç
Á¤Ã¥ · ¹ý·ü
Á¦¾à · ¹ÙÀÌ¿À
¾à±¹ · º´¿ø
Ä«µå´º½º
ÆÊTV
À̽´¿µ»ó
DPÃÊ´ë¼®
À̽´Áø´Ü
¾Ë¾Æº¸Àâ
¿ÀÇǴϾð
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
±âÀÚ¼öø
Ưº°±â°í
English
Policy
Opinion
Company
Product
Interview
TVÆÊµµ¶ó
ÆÊTube
ÆÊ¼îÇÎ
³ª´Â¾à»ç´Ù
ÆÊµå¶ó¸¶
ÆÊ¾ÆÄ«µ¥¹Ì
ÃʽÉŬ·¡½º
OTC»ó´ã
Á¦Ç°°ÁÂ
Çмú°ÁÂ
°æ¿µ°ÁÂ
Ä¿¹Â´ÏƼ
ÆÊ¸®Äí¸£Æ®
ä¿ëÁ¤º¸
PHARMARCY
ÀÎÀçÁ¤º¸
DPºÎµ¿»ê
¾à±¹ Q&A
¾à»ç´ëÃâ
¾à»ç½Å¿ë´ëÃâ
¼¼¹«»ó´ã
¼¼¹«·³ë¹«
¹ý·ü»ó´ã
¾à±¹°æ¿µ°úâ¾÷
ÀǾàÀÚ·á½Ç
ÀǾàÇàÁ¤
¾à»ç¾à±¹
ÀǷẴ¿ø
Á¦¾àÀ¯Åë
º¸µµÀÚ·á
ÆÊ½ºÅ¸Å¬·´
ÀÎ»ç · ºÎÀ½
¾à±¹ÀåÅÍ
ȸ»ç¼Ò°³
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
»ç¾÷Á¦ÈÞ
ÀÎÅͳݽŹ®À±¸®°·É
µ¶ÀÚÁ¦º¸
±âÀÚÀ±¸®°·É
ÀÚÀ²¼¾à¼
¿ø°ÝÁö¿ø¿äû
Event & ¼¼¹Ì³ª
Àüü±â»ç
±×·¡ÇÈ
Á¤Ã¥¡¤¹ý·ü
Á¦¾à¡¤¹ÙÀÌ¿À
¾à±¹¡¤º´¿ø
±âȹ¡¤Å½»ç
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
񃯇
񃯇
ÀǾàǰ
³¹¾Ë½Äº°
µ¥Àϸ®ÆÊ Live Search
´Ý±â
´º½º
>
Àüü ±â»ç
Àüü Çìµå¶óÀÎ ±â»ç
Àüü
|
05-17 (Åä)
|
05-16 (±Ý)
|
05-15 (¸ñ)
|
05-14 (¼ö)
|
05-13 (È)
|
05-12 (¿ù)
|
05-11 (ÀÏ)
"ó¹æ Ư A±Þ ÀÚ¸®"...ÄÁ¼³ÆÃ Á¤º¸ ÀÇ½É ¶Ç ÀǽÉÀ»
2025-05-14 12:04:54
[µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ¾à±¹ ÀÚ¸® °è¾àÀ» À§ÇØ ÀÇ·á±â°ü ó¹æ °Ç¼ö¸¦ ºÎÇ®¸®°Å³ª, ´Ü¼ø ±â´ëÄ¡¸¦ ¹Ý¿µÇÏ´Â ÄÁ¼³ÆÃ »ç·Ê°¡ À̾îÁö°í ÀÖ¾î ÁÖÀǰ¡ ¿ä±¸µÈ´Ù. ÇÇÇØ¸¦...
°Çý°æ ±âÀÚ
"¹Ì±¹ Çõ½Å ÀǾàǰ ÇöÁö »ý»ê...°ü¼¼ ºÎ°ú½Ã ÀÚ±¹ ºÎ´ã¡è"
2025-05-14 12:00:50
[µ¥Àϸ®ÆÊ=±èÁø±¸ ±âÀÚ] ¹Ì±¹ Á¤ºÎ°¡ ÀǾàǰ¿¡ 25%ÀÇ °ü¼¼¸¦ ºÎ°úÇÒ °æ¿ì ¿¬ 508¾ï ´Þ·¯(¾à 72Á¶¿ø)¿¡ ´ÞÇÏ´Â ºñ¿ë ºÎ´ãÀÌ Áõ°¡ÇÒ °ÍÀ̶õ ¿ì·Á°¡ ÇöÁö¿¡¼ Á¦±âµÆ´Ù. ¹Ì...
±èÁø±¸ ±âÀÚ
GSK ¾Æ·º½ººñ, RSV ¹é½Å½ÃÀå µµÀüÀå...NIP ÁøÀÔ °ü°Ç
2025-05-14 11:55:33
[µ¥Àϸ®ÆÊ=Ȳº´¿ì ±âÀÚ] GSK°¡ RSV(È£Èí±â¼¼Æ÷À¶ÇÕ¹ÙÀÌ·¯½º) ¹é½Å ¾Æ·º½ººñ(Arexvy)¸¦ ±¹³»¿¡ Ãâ½ÃÇÏ¸é¼ º»°ÝÀûÀÎ ½ÃÀå °ø·«¿¡ ³ª¼±´Ù. ÀÌ¹Ì ±Û·Î¹ú ½ÃÀå¿¡¼ ù RS...
Ȳº´¿ì ±âÀÚ
°Ç¾à "°í·ÉÈ¡¤°í°¡½Å¾à¿¡ 5³â°£ ¾àÁ¦ºñ ±ÞÁõ¡¦ÀçÁ¤ºÎ´ã"
2025-05-14 11:53:19
[µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] °Ç°»çȸ¸¦À§ÇѾà»çȸ(´ëÇ¥ Àü°æ¸², ÀÌÇÏ °Ç¾à)°¡ ÀǾàǰ ǰÀý »çÅ¿¡ ´ëÇÑ ´ë¾È Á¦½Ã¿¡ À̾î Àα¸ °í·ÉÈ¿Í °í°¡ ½Å¾à Áõ°¡·Î ÀÎÇÑ °Ç°º¸Çè...
°Çý°æ ±âÀÚ
¼¿À§¹ö½º, Á¤º¸Åë½Å»ê¾÷ÁøÈï¿ø AI ¹Ù¿ìó »ç¾÷ ¼±Á¤
2025-05-14 11:20:25
[µ¥Àϸ®ÆÊ=Ȳº´¿ì ±âÀÚ] ¹ÙÀÌ¿À ½ºÅ¸Æ®¾÷ ¼¿À§¹ö½º(Cellweaverse)°¡ Á¤º¸Åë½Å»ê¾÷ÁøÈï¿ø(NIPA)ÀÌ ÁÖ°üÇÏ´Â 2025³âµµ AI ¹Ù¿ìó Áö¿ø »ç¾÷¿¡ ÃÖÁ¾ ¼±Á¤µÆ´Ù°í 14ÀÏ ¹àÇû...
Ȳº´¿ì ±âÀÚ
GC³ì½ÊÀÚ "¹Ì±¹ Ç÷Àå¼¾ÅÍ 6°÷ FDA Çã°¡ ¿Ï·á"
2025-05-14 10:42:20
[µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] GC³ì½ÊÀÚ´Â Áö³ 13ÀÏ ¹Ì±¹ ÀÚȸ»ç ABOȦµù½ºÀÇ Ä¶¸®Æ÷´Ï¾ÆÁÖ Ä®·º½ÃÄÚ(Calexico) Ç÷Àå ¼¾ÅͰ¡ ¹Ì±¹ ½ÄǰÀǾàǰ±¹(FDA) Çã°¡¸¦ ȹµæÇß´Ù°í 14ÀÏ...
õ½ÂÇö ±âÀÚ
µ¿¿ø¾àǰ±×·ì¡¤º¹»ê³ªÀ̽º¡¤½ºÁîÄË, ÀÚº»¾÷¹« Á¦ÈÞ
2025-05-14 10:24:55
[µ¥Àϸ®ÆÊ=Â÷ÁöÇö ±âÀÚ] µ¿¿ø¾àǰ±×·ì 8°³»ç¿Í º¹»ê³ªÀ̽º, ½ºÁîÄËÀº ¾÷¹«Á¦ÈÞ °è¾àÀ» ü°áÇÏ°í ¿¬ÇÕü Â÷¿øÀÇ »ç¾÷ Çù·ÂÀ» À§ÇÑ Ã¼°è¸¦ ±¸ÃàÇß´Ù°í 14ÀÏ ¹àÇû´Ù. ½º...
Â÷ÁöÇö ±âÀÚ
´ë¿õ, 'Æå¼öŬ·ç' 20mg Çã°¡...NSAIDs ¿¹¹æ ÀûÀÀÁõ È®º¸
2025-05-14 10:21:51
[µ¥Àϸ®ÆÊ=ÀÌÇý°æ ±âÀÚ] ´ë¿õÁ¦¾àÀÌ Ä®·ý °æÀïÀû À§»êºÐºñ ¾ïÁ¦Á¦(P-CAB) °è¿ À§½Äµµ¿ª·ùÁúȯ Ä¡·áÁ¦ Æå¼öŬ·çÁ¤(Æå¼öÇÁ¶óÀÜ¿°»ê¿°)ÀÇ »õ·Î¿î ¿ë·®À» Çã°¡ ¹ÞÀ¸¸é¼ ...
ÀÌÇý°æ ±âÀÚ
AI±â¹Ý ½Å¾à°³¹ß ½ºÄÉÀϾ÷¡¦¹ÙÀÌ¿Àº¥Ã³ ±â¼ú°íµµÈ ³íÀÇ
2025-05-14 10:17:45
[µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] AI ±â¹Ý ±â¼ú ½ºÄÉÀϾ÷¿¡ ´ëÇÑ Ã»»çÁø ³íÀǰ¡ ÀÌ·ïÁ³´Ù. Çѱ¹»ý¸í±â¼ú¿¬±¸Á¶ÇÕ(ÀÌ»çÀå ¹Ú¹Ì¿µ)°ú Çѱ¹»ý¸í°øÇבּ¸¿ø ±¹°¡ÀüÀÓ»ó½ÃÇèÁö¿ø¼¾...
°Çý°æ ±âÀÚ
ÀÇÇù "ÇÑÀÇ»ç´Üü ¿Ö°î°ú °ÅÁþ¡¤¼±µ¿ Áß´ÜÇ϶ó"
2025-05-14 10:15:25
[µ¥Àϸ®ÆÊ=°½Å±¹ ±âÀÚ] ÀǷ῵¿ªÀ» ³õ°í ÀÇ»ç¿Í ÇÑÀÇ»çÀÇ ¹Ý¸ñÀÌ °è¼ÓµÇ°í ÀÖ´Ù. ´ëÇÑÀÇ»çÇùȸ Çѹæ´ëåƯº°À§¿øÈ¸´Â 14ÀÏ ¾ç´ç ´ë¼± È常¦ ¸ð½Ã°í Åä·Ðȸ¸¦ Áï°¢...
°½Å±¹ ±âÀÚ
1
2
3
4
5
ä¿ë
¼Óº¸
ÁÖ¹®½Ã °áÁ¦±Ý¾×ÀÇ 5% Áï½Ã ÇÒÀÎ!
Å»¸ð¼¤Çª1À§¡Ú¸ðÅ彺¼¤Çª
44%
29,450¿ø
[¿À¶óƽ½º] ±¸°À¯»ê±Õ 5°³¿ùºÐ
62%
85,500¿ø
NEW ûÁ¤¿ø Á¤¼º12È£
37%
17,900
µå¸²ÀÌÀ½ ¾ËÆÄ½ÃŬ·Î µ¦½ºÆ®¸° ´ÙÀÌ·ºÆ® ¾ËÆÄ
35%
11,000
ÀÓ»êºÎ ¸®Æ÷ÆÛ ¾×»ó öºÐÁ¦
50%
15,000
¹Ù¸£´Â ÆÄ½º Ä𸵠½ºÆ÷Ã÷°Ö
5%
9,500¿ø
[¿À¶óƽ½º] ÀÓÇöõƽ½º 5°³¿ùºÐ
61%
118,750¿ø
È«»ïÁ¤ ¿¡ºê¸®Å¸ÀÓ ·Õ±â½ºÆ®
65%
31,900
¾ÆÀÌ¿ø Ŭ¸®³Ê¼¼Á¤ 20¸ÅÀÔ
12%
88,825¿ø
Çã´Ï¿¡¼¾½º ¸®À¯ÀúºíÄÅ ²Ü ¼±¹°¼¼Æ®
29%
34,300
¾ß»ý ºôº£¸®&¶óÁ¸® 6ÆÑ
25%
32,300¿ø
¿Ãµ¥ÀÌ KF94 ¸¶½ºÅ©
8%
250¿ø
[Çϸ²] ¿ë°¡¸® ġŲ³Ê°Ù 1+1
38%
17,005¿ø
[»ïÇö] ¼Òµ¶¿ë¿¡Åº¿Ã
5%
760¿ø
[¶ó¿¤] À¯±â³ó ¼ø¸é »ý¸®´ë
34%
5,605¿ø
µ¿¿øÂüÄ¡ Á¾ÇÕ A1È£
30%
17,500
[¸ÅÁ÷½¦ÇÁ] ¹Ì´Ï Á¦½À±â
37%
35,625
[¾¾¸®¾ó¸¶ÄÏ] ¹Ù»èÇÑ ¼ÓÃÊ ¸ÔÅÂ
46%
18,900
[Á¤°üÀå] Àå»ý±âº¸ 30Æ÷
50%
149,000
¹Ì¶óŬÅ彺 ¾îµå¹ê½ºµå ÆäÀÌ¼È Å¬·»Àú
50%
27,500
¹Ì¶óŬÅ彺 ¾îµå¹ê½ºµå ¸®ÇÁÆÃ ¾ÚÇÃ
50%
44,000
µ¿¿ø °Ç°ÇÑÂüÄ¡ ¼±¹°¼¼Æ®
30%
35,500
ºí·¢¾Þ°Å½º LA²É°¥ºñ ¼±¹°¼¼Æ®
79%
53,500
°üÀý¿£ ö°©»ó¾î&¼Ò¿¬°ñ Äܵå·ÎÀÌÄ£ ¹ÂÄÚ´Ù´ç´Ü¹é
26%
14,700
¾Ë¸² ¡¤ °øÇ¥
±³À° ¡¤ °ÁÂ
¾à±¹ Q&A
Á¢¼ö ¡¤ ¹®ÀÇ
°øÇ¥
JW½Å¾à ÀǾàǰ(ÆÄ³ª´ýÅ©¸²) ȸ¼ö¿¡ °üÇÑ °øÇ¥
¾Ë¸²
½Å°³³ä »êÁ¦Çü ¸Ö¹Ì¾à, ½ºÅä¸Ö»ê! POP & ¹æ¹®½Åû ¢º
¾Ë¸²
[µ¿¾ÆÁ¦¾à]Å»¸ð»ó´ãÀÇ ÇØ´ä, Ä«ÇÊ·¯½º À̺¥Æ® GO¢º
¾Ë¸²
ÁøÅëÁ¦ ½À°ü Àâ´Â ±â¼ú! ʼ¾ »ó´ã °¡ÀÌµå ¹Þ±â ¢º
¾Ë¸²
ÆÊ½ºÅ¸Å¬·´ ·ê·¿ÄíÆù ¡æ ÆÊÆ÷ÀÎÆ® ±³È¯ À̺¥Æ® GO ¢º
°øÇ¥
(ÁÖ)ÆÊÁ¨»çÀ̾𽺠ÀǾàǰ ȸ¼ö¿¡ °üÇÑ °øÇ¥
¾Ë¸²
NCA ÁÖÄ¡¾à»ç 3±â ¸ðÁý!
°øÇ¥
JW½Å¾à ÀǾàǰ(³ª¹«Á¹Á¤) ȸ¼ö¿¡ °üÇÑ °øÇ¥
D-109
ij³ª´Ù¾à»ç ½ÃÇè, ÀÌ·¸°Ô ¹Ù²ï´Ù! ( ~12.31 )
D-109
¾à¾÷°è ´ëÇ¥ ±³À°»çÀÌÆ®, ÆÊŬ·¡½º ( ~12.31 )
D-3
SGLT ¾ïÁ¦Á¦ ÇÙ½É º¹¾àÁöµµ ¢º»çÀü½Åû ( ~9.16 )
D-6
PV ¾÷¹«¿ª·® °È±³À° ¼ö°½Åû ¢º ( ~9.19 )
D-13
ÈѽºÅ»·Î Àд ¼ÒÈÁ¦ Æ®·»µå µî·Ï¢º ( ~9.26 )
ÀÚ»ê°ü¸®
Á¾½Åº¸Çè °è¾àÀÚ¿Ü ¼öÀÍÀÚ º¯°æ °¡´ÉÇѰ¡¿ä?
¼¼¹«¡¤³ë¹«
(±Ù¹«¾à»ç ÁßµµÅð»ç) Ãß°¡ Áú¹®µå¸³´Ï´Ù
¹ý·ü»ó´ã
¸éÇã´ë¿©¾à±¹¿¡´ëÇÑ Áú¹®
¾à±¹°æ¿µ°ú â¾÷
¾à±¹Ã¢¾÷°ü·Ã
¼¼¹«»ó´ã
±Ç¸®±ÝÀ» ³ª´²¼ ½Å°í ÇÒ ¼ö µµ ÀÖ³ª¿ä?
¾à±¹´ëÃâ
¾à±¹¿î¿µÀÚ±Ý
±³À° °Á ¹× ¾Ë¸² ±¤°í ¾È³» ÆäÀÌÁö
¿¬¼ö, ±³À°, ¼¼¹Ì³ª, Çмú°Á ¹× ±â¾÷±³À°, ¸ðÁý
°øÇ¥, Åä·Ðȸ, ÀǾàǰ º¯°æ ¾È³» ¹× °¢Á¾ Çà»ç
¾Ë¸² ±¤°í¸¦ ÇØµå¸³´Ï´Ù.
(Á¢¼ö ¹®ÀÇ ¹Ù·Î°¡±â)
¿À´ÃÀÇ
ÇÖ´º½º
1
K-ºäƼ µî¿¡ ¾÷°í ¸íµ¿¿¡ ´ëÇü¾à±¹ °³¾÷...¿ù¼¼¸¸ 1.2¾ï
2
¾Æ¸ñ½Ã½Ç¸° ´ë¶õ...°ÅÁþÁ¤º¸¡æSNS¡æ¾à±¹ ±Þ¼Ó ÀüÆÄ
3
Àκ¸»ç ¹Ì±¹ ÁøÃâ Àڽۨ?...ÄÚ¿À·ÕƼ½´Áø, 1225¾ï Á¶´Þ
4
¿ïÆ®¶ó¼Â Á¦³×¸¯, ù ºÒ¼ø¹° Ãʰú °ËÃ⡦ȸ¼ö È®´ëµÇ³ª
5
±Þ¿© ºÒÈ®½Ç¼º ÇØ¼Ò...Á¡¾ÈÁ¦ ¾÷ü »ý»ê´É·Â È®´ë °æÀï
6
Ç÷§Æû 'Çã°¡Á¦' ºñ´ë¸é Áø·á¹ý ¹ßÀÇ Ã¤ºñ¡¦ºÒ¹ý Â÷´Ü
7
±¹È¸ ȨÇÇ¿¡ ¸ô·Áµç ÀǾà»çµé, ¼ººÐ¸íó¹æ ÀÔ¹ý ÀüÀï
8
ºä³ë, ÀÚ»ê 2°Ç ¸Å°¢¡¦°íºÎ°¡°¡Ä¡ »ç¾÷ '¼±Åðú ÁýÁß'
9
ºñ¿ë È¿°ú¼º È®ÀÎÇÑ º£ÀÌÆ÷Åõ½º, NIP ³íÀÇ '±ººÒ'
10
¾Æ¸ñ½Ã½Ç¸° ¹®ÀÚ¸Þ½ÃÁö µ¹ÀÚ °ü·Ã Á¦Ç° ¿¬¼â ǰÀý